Sign In
Buy ALNY
$297.69
+5.53 (+1.89%)
At Close: Jun 09, 2026
Alnylam's (ALNY) Lumasiran NDA Gets Priority Review From FDA
01:47pm, Wednesday, 27'th May 2020
Alnylam's (ALNY) NDA seeking approval for lumasiran for treating kidney disease, primary hyperoxaluria type 1, gets priority review from the FDA.
Alnylam Pharmaceuticals : to Webcast Presentations at Upcoming June Investor Conferences | MarketScreener
08:02pm, Tuesday, 26'th May 2020Alnylam to Webcast Presentations at Upcoming June Investor Conferences
08:00pm, Tuesday, 26'th May 2020
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following conferences being held virtually:
New Coronavirus Vaccine Candidate: Novavax Starting Clinical Trials Of NVX-COV2373 To Fight Pandemic
02:36pm, Tuesday, 26'th May 2020
The first phase of the trial will enroll 130 healthy individuals ages 18 to 59 and take place in Australia while phase 2 will be conducted in multiple countries and widen the age range.
Pfizer Is Charging Ahead With A Coronavirus Vaccine — Is PFE Stock A Buy?
12:00pm, Tuesday, 26'th May 2020
Pfizer stock could see some gains in 2020 if it makes progress on a coronavirus vaccine with BioNTech. But its Upjohn merger with Mylan is now delayed. Is Pfizer stock a buy now?
New Coronavirus Vaccine To Send Virus' Spike Protein To Activate Body's Immune Response
12:00pm, Tuesday, 26'th May 2020
Novavax is now beginning its clinical trials.
Alnylam Announces FDA Has Granted Priority Review Of Lumasiran New Drug Application For Primary Hyperoxaluria Type 1
11:01am, Tuesday, 26'th May 2020Edited Transcript of ALNY earnings conference call or presentation 6-May-20 12:30pm GMT
11:00am, Tuesday, 26'th May 2020
Q1 2020 Alnylam Pharmaceuticals Inc Earnings Call
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the Company’s New Drug Application
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the U.S. Food and Drug Administration (FDA)
Is Alnylam Pharmaceuticals (ALNY) Outperforming Other Medical Stocks This Year?
03:30pm, Monday, 25'th May 2020
Is (ALNY) Outperforming Other Medical Stocks This Year?
HCQ: what we know so far
10:58am, Monday, 25'th May 2020
India has extended guidelines for hydrochloroquine use, a study has raised fresh questions about its efficacy against Covid, and Trump continues to push for it. A look at both sides of the continuing
National security adviser says US considering banning travel from Brazil over coronavirus outbreak
03:16pm, Sunday, 24'th May 2020
National security adviser Robert O'Brien said the United States will make a decision on whether to ban travel from Brazil on Sunday.
